SGC
GEHC icon

Slocum, Gordon & Co’s GE HealthCare GEHC Stock Holding History

Slocum, Gordon & Co’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$7.41K – 84
2025
Q2 		$7.41K Hold
100
– – 0.01% 107
2025
Q1 		$8.07K Sell
100
-2,885
-97% -$248K 0.01% 115
2024
Q4 		$233K Sell
2,985
-62
-2% -$5.27K 0.19% 50
2024
Q3 		$286K Sell
3,047
-92
-3% -$7.72K 0.12% 50
2024
Q2 		$245K Sell
3,139
-370
-11% -$30.2K 0.18% 47
2024
Q1 		$319K Hold
3,509
– – 0.24% 44
2023
Q4 		$271K Sell
3,509
-26
-0.7% -$1.82K 0.24% 43
2023
Q3 		$240K Sell
3,535
-135
-4% -$9.82K 0.21% 45
2023
Q2 		$298K Sell
3,670
-154
-4% -$12.3K 0.22% 41
2023
Q1 		$314K Buy
+3,824
New +$273K 0.26% 41

Other funds holding GEHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Slocum, Gordon & Co's GEHC Position: Q3 2025 in Review

Slocum, Gordon & Co sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 100 shares — an estimated $7.41K sold.

Slocum, Gordon & Co first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $319K in Q1 2024. 1,278 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Slocum, Gordon & Co reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Slocum, Gordon & Co sold 100 GE HealthCare shares in Q3 2025, an estimated $7.41K.
  • Slocum, Gordon & Co first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Slocum, Gordon & Co's GE HealthCare position peaked at $319K in Q1 2024.
  • 1,278 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Slocum, Gordon & Co's 13F filing for Q3 2025, filed 17 Oct 2025.